Effectiveness of the soluble form of the interleukin‐1 receptor accessory protein as an inhibitor of interleukin‐1 in collagen‐induced arthritis
Abstract
To investigate whether the soluble form of interleukin‐1 (IL‐1) receptor accessory protein (sIL‐1RAcP), whose physiologic function remains to be established, can serve as a specific inhibitor of IL‐1 signaling in vitro, and to evaluate its applicability in collagen‐induced arthritis (CIA).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 01, 2003
- Source ID
- 10.1002/art.11234
Entities
People
- David T. Curiel
- F. A. J. Van De Loo
- I. P. Dmitriev
- L. A. B. Joosten
- M. B. Bennink
- M. U. Martin
- O. J. Arntz
- R. L. Smeets
- W. A. Loesberg
- W. B. Van Den Berg
Organizations
- National Institutes of Health
- United States Department of Defense